Avastin

Jobevne (Bevacizumab) Gains FDA Nod, Biocon Expands US Oncology Biosimilars Portfolio
Xtalks
Sun, 04/13/25 - 11:15 pm
Jobevne
bevacizumab-nwgd
Biocon Biologics
biosimilars
Avastin
cancer
FDA
Roche condemns 'act of counterfeiting' as authorities in Pakistan crack down on unapproved Avastin use
Fierce Pharma
Mon, 09/25/23 - 07:42 pm
Roche
Avastin
Pakistan
drug counterfeiting
Genentech reveals positive results from cancer combo therapy trial
Clinical Trials Arena
Mon, 04/17/23 - 11:24 am
Genentech
Tecentriq
Avastin
liver cancer
hepatocellular carcinoma
FDA rejects Biocon and Viatris' Avastin biosimilar after inspection question marks
Endpoints
Mon, 02/13/23 - 10:02 pm
FDA
Biocon
Viatris
Avastin
biosimilars
drug manufacturing
Roche’s Tecentriq to be filed for early-stage liver cancer
Pharmaphorum
Thu, 01/19/23 - 09:41 am
Roche
Tecentriq
Avastin
clinical trials
liver cancer
FDA Approves Avastin Biosimilar for Six Types of Cancer
Pharmacy Times
Wed, 09/28/22 - 10:30 pm
FDA
biosimilars
Vegzelma
Avastin
non-small cell lung cancer
glioblastoma
metastatic colorectal cancer
cervical caner
metastatic renal cell carcinoma
Microcap's effort to take on Eylea with Avastin biosimilar faces significant FDA roadblock
Endpoints
Tue, 05/31/22 - 10:51 am
Outlook Therapeutics
Avastin
biosimilars
wet age-related macular degeneration
Roche
bevacizumab
Roche Wakes Up to New Competition as FDA Approves Amneal’s Avastin Biosimilar
BioSpace
Thu, 04/14/22 - 10:57 am
Amneal
FDA
bevacizumab-maly
Genentech
Roche
Avastin
biosimilars
Merck fleshes out Keytruda win in first-line cervical cancer, adding more firepower to its early cancer push
Endpoints
Sat, 09/18/21 - 08:29 pm
ESMO
Merck
Keytruda
Roche
Avastin
cervical cancer
Outlook heads to regulators with eye-friendly Avastin
EP Vantage
Wed, 08/4/21 - 10:53 am
Outlook Therapeutics
Avastin
age-related macular degeneration
FDA
Lucentis
Roche nabs frontline OK for Avastin/Tecentriq in common liver cancer, besting an old Bayer drug
Endpoints
Mon, 06/1/20 - 10:24 am
Roche
Avastin
Tecentriq
metastatic hepatocellular carcinoma
liver cancer
FDA
Bio-Thera Solutions announces positive top-line results for BAT1706, a proposed biosimilar to Avastin
Pharmaceutical Business Review
Tue, 02/4/20 - 10:05 am
BAT1706
Bio-Thera Solutions
Avastin
Roche
non-squamous non-small cell lung cancer
biosimilars
Pfizer launches biosimilars to Roche’s ‘big three’ cancer drugs in US
Pharmaforum
Fri, 01/24/20 - 10:11 am
Pfizer
Roche
biosimilars
Avastin
Zirabev
Herceptin
Trazimera
Rituxan
Ruxience
Innovent and Coherus Strike Licensing Agreement for Avastin Biosimilar
BioSpace
Thu, 01/16/20 - 11:14 pm
China
Innovent Biologics
Coherus Biosciences
biosimilars
Avastin
Roche shows Tecentriq/Avastin combo helps liver cancer patients live longer
Endpoints
Mon, 11/25/19 - 09:47 am
Roche
Tecentriq
Avastin
liver cancer
China
Bayer
Nexavar
clinical trials
Roche's Tecentriq scores a first-in-class double win in new liver cancer patients
Fierce Pharma
Mon, 10/21/19 - 04:36 pm
Roche
liver cancer
Tecentriq
immuno-oncology
Avastin
Nexavar
ESMO: AZ, Merck's Lynparza chases Avastin combo nod with big ovarian cancer win
Fierce Pharma
Sat, 09/28/19 - 04:49 pm
Roche
Avastin
ovarian cancer
AstraZeneca
Merck
Lynparza
ESMO
Amgen biosimilar debut boosted by UnitedHealthcare coverage switch
Biopharma Dive
Mon, 08/19/19 - 11:52 am
insurers
Amgen
biosimilars
Avastin
Herceptin
Roche
UnitedHealthcare
Roche doomsday is here: Long-feared Herceptin, Avastin biosims bust into U.S. market
Fierce Pharma
Fri, 07/19/19 - 07:28 pm
Herceptin
Avastin
Roche
biosimilars
Allergan
Amgen
Another Biosimilar Approval From FDA, Another Unknown Launch Date
RAPS.org
Fri, 06/28/19 - 12:31 pm
Pfizer
Zirabev
biosimilars
FDA
Roche
cancer
Avastin

Pages